Is ACRXF Stock Undervalued?
A comprehensive valuation analysis of Acerinox S.A. (ACRXF) examining current multiples, intrinsic value, and comparing to analyst expectations.
Valuation Verdict
Fairly Valued
0.0% downside risk
Based on our analysis, Acerinox S.A. appears to be fairly valued at the current price of $15.40.
Current Valuation Metrics
Valuation ratios help us understand how the market is pricing ACRXF relative to its fundamentals. Let's examine the key multiples investors are paying today.
Understanding the Metrics
- P/E Ratio: Not currently profitable or data unavailable.
- P/B Ratio: A P/B of 1.58 means investors pay $1.58 for every $1 of book value.
- P/S Ratio: The price-to-sales ratio of 0.66 indicates how much investors value each dollar of revenue.
- EV/EBITDA: This ratio of 12.05 helps compare ACRXF to peers while accounting for debt.
Fair Value Estimate
Using a discounted cash flow (DCF) model, we estimate the intrinsic value of Acerinox S.A. stock. This fundamental analysis looks at the company's ability to generate future cash flows and discounts them back to today's value.
Unable to calculate a reliable fair value estimate due to insufficient financial data or negative cash flows. This is common for early-stage growth companies or those undergoing restructuring.
Investment Conclusion
Bottom Line
Acerinox S.A. (ACRXF) appears fairly valued at $15.40, trading in line with our fundamental analysis. The stock may be appropriate for investors seeking exposure to Basic Materials without significant valuation risk.
Disclaimer: This analysis is for informational purposes only and should not be considered investment advice. Always conduct your own research and consult with a financial advisor before making investment decisions. Past performance does not guarantee future results.
More Analysis for ACRXF
Compare with Peers
See how Acerinox S.A. stacks up against similar companies
Popular Valuation Analysis
Explore valuation analysis for top stocks
Related: ACRXF Dividend, ACRXF Growth, ACRXF Financial Health
Compare: ACRXF vs AAPL, ACRXF vs MSFT, ACRXF vs GOOGL